Biomarker-matched drug combos shrink treatment-resistant melanoma in preclinical models

A new study led by researchers at The University of Texas MD Anderson Cancer Center has identified a way to tailor drug ...
News-Medical.Net

Tailored drug combinations improve outcomes for treatment-resistant advanced melanoma

A new study led by researchers at The University of Texas MD Anderson Cancer Center has identified a way to tailor drug ...
Mirage News

Biomarker-Driven Drug Combos Boost Melanoma Outcomes

HOUSTON, JULY 2, 2026 ― A new study led by researchers at The University of Texas MD Anderson Cancer Center has identified a way to tailor drug ...